The DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.
Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer’s disease
Open accessAbstract
Patients with Alzheimer's disease can present with different clinical phenotypes. Individuals with late-onset Alzheimer's disease (>65 years) typically present with medial temporal lobe neurodegeneration and predominantly amnestic symptomatology, while patients with early-onset Alzheimer's disease (<65 years) exhibit greater neocortical involvement associated with a clinical presentation including dyspraxia, executive dysfunction, or visuospatial impairment. We recruited 20 patients with early-onset Alzheimer's disease, 21 with late-onset Alzheimer's disease, three with prodromal early-onset Alzheimer's disease and 13 with prodromal late-onset Alzheimer's disease, as well as 30 cognitively healthy elderly controls, that had undergone 18F-AV-1451 tau positron emission tomography and structural magnetic resonance imaging to explore whether early- and late-onset Alzheimer's disease exhibit differential regional tau pathology and atrophy patterns. Strong associations of lower age at symptom onset with higher 18F-AV-1451 uptake were observed in several neocortical regions, while higher age did not yield positive associations in neither patient group. Comparing patients with early-onset Alzheimer's disease with controls resulted in significantly higher 18F-AV-1451 retention throughout the neocortex, while comparing healthy controls with late-onset Alzheimer's disease patients yielded a distinct pattern of higher 18F-AV-1451 retention, predominantly confined to temporal lobe regions. When compared against each other, the early-onset Alzheimer's disease group exhibited greater uptake than the late-onset group in prefrontal and premotor, as well as in inferior parietal cortex. These preliminary findings indicate that age may constitute an important contributor to Alzheimer's disease heterogeneity highlighting the potential of tau positron emission tomography to capture phenotypic variation across patients with Alzheimer's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Elevated tau PET binding in both medial temporal lobe structures and the neocortex is strongly associated with positive amyloid PET scans and with clinical impairment across the normal aging to dementia clinical spectrum [82,130–141].”
From NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease (2018) · cites this paper as [137]
In the citing paper
“Recent tau PET studies with [18F]flortaucipir showed that EOAD had greater tau burden in the neocortex compared to LOAD patients (Cho et al., 2017; Schöll et al., 2017).”
From Effects of Alzheimer’s and Vascular Pathologies on Structural Connectivity in Early- and Late-Onset Alzheimer’s Disease (2021) · cites this paper as Schöll et al., 2017
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Voxel-Based Morphometry—The Methods
Ashburner, J., & Friston, K. J. (2000) · NeuroImage · doi:10.1006/nimg.2000.0582 · Cited by 8,676
Automatically Parcellating the Human Cerebral Cortex
Fischl, B. R. (2003) · Cerebral Cortex · doi:10.1093/cercor/bhg087 · Cited by 4,208
Cognitive reserve in ageing and Alzheimer's disease
Stern, Y. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70191-6 · Cited by 3,557
Scheltens, P., Blennow, K., Breteler, M. M. B., de Strooper, B., Frisoni, G. B., Salloway, S., & Van der Flier, W. M. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01124-1 · Cited by 3,125
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Feldman, H. H., Frisoni, G. B., Hampel, H., Jagust, W. J., Johnson, K. A., Knopman, D. S., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002923 · Cited by 1,864
Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia: A Meta-analysis
Jansen, W. J., Ossenkoppele, R., Knol, D. L., Tijms, B. M., Scheltens, P., Verhey, F. R. J., Visser, P. J., Aalten, P., Aarsland, D., Alcolea, D., et al. (2015) · JAMA · doi:10.1001/jama.2015.4668 · Cited by 1,610
Self-citationPET Imaging of Tau Deposition in the Aging Human Brain
Schöll, M., Lockhart, S. N., Schonhaut, D. R., O’Neil, J. P., Janabi, M., Ossenkoppele, R., Baker, S. L., Vogel, J. W., Faria, J., Schwimmer, H. D., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.01.028 · Cited by 1,214
Self-citation
Cited by
Sorted by citations
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
Johnson, E. C. B., Dammer, E. B., Duong, D. M., Ping, L., Zhou, M., Yin, L., Higginbotham, L. A., Guajardo, A., White, B., Troncoso, J. C., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0815-6 · Cited by 1,001
Imaging the evolution and pathophysiology of Alzheimer disease
Jagust, W. (2018) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0067-3 · Cited by 604
Amyloid-β-independent regulators of tau pathology in Alzheimer disease
van der Kant, R., Goldstein, L. S. B., & Ossenkoppele, R. (2020) · Nature reviews. Neuroscience · doi:10.1038/s41583-019-0240-3 · Cited by 580
Self-citationOssenkoppele, R., Rabinovici, G. D., Smith, R., Cho, H., Schöll, M., Strandberg, O., Palmqvist, S., Mattsson, N., Janelidze, S., Santillo, A., et al. (2018) · JAMA · doi:10.1001/jama.2018.12917 · Cited by 472
Self-citationLongitudinal tau PET in ageing and Alzheimer’s disease
Jack, C. R., Wiste, H. J., Schwarz, C. G., Lowe, V. J., Senjem, M. L., Vemuri, P., Weigand, S. D., Therneau, T. M., Knopman, D. S., Gunter, J. L., et al. (2018) · Brain · doi:10.1093/brain/awy059 · Cited by 452
A walk through tau therapeutic strategies
Jadhav, S., Ávila, J., Schöll, M., Kovács, G. G., Kövari, E., Škrabana, R., Evans, L., Kontseková, E., Malawska, B., de Silva, R., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0664-z · Cited by 299
Self-citationPontecorvo, M. J., Devous, M. D., Kennedy, I., Navitsky, M., Lu, M., Galante, N., Salloway, S., Doraiswamy, P. M., Southekal, S., Arora, A. K., et al. (2019) · Brain · doi:10.1093/brain/awz090 · Cited by 249
PET imaging of neuroinflammation in neurological disorders
Kreisl, W. C., Kim, M.-J., Coughlin, J. M., Henter, I. D., Owen, D. R., & Innis, R. B. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30346-x · Cited by 254
Tau burden and the functional connectome in Alzheimer’s disease and progressive supranuclear palsy
Cope, T., Rittman, T., Borchert, R. J., Jones, P. S., Vatansever, D., Allinson, K. S. J., Passamonti, L., Rodríguez, P. V., Bevan-Jones, W. R., O'Brien, J. T., et al. (2017) · Brain · doi:10.1093/brain/awx347 · Cited by 251
Palmqvist, S., Warmenhoven, N., Anastasi, F., Pilotto, A., Janelidze, S., Tideman, P., Stomrud, E., Mattsson, N., Smith, R. A., Ossenkoppele, R., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03622-w · Cited by 267
Self-citationSchöll, M., Maaß, A., Mattsson, N., Ashton, N. J., Blennow, K., Zetterberg, H., & Jagust, W. J. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.12.001 · Cited by 248
Self-citationEarly-onset Alzheimer Disease and Its Variants
Mendez, M. F. (2019) · Continuum · doi:10.1212/con.0000000000000687 · Cited by 307
Early-Onset Alzheimer’s Disease: What Is Missing in Research?
Ayodele, T., Rogaeva, E. A., Kurup, J. T., Beecham, G. W., & Reitz, C. (2021) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-020-01090-y · Cited by 210
The development and validation of tau PET tracers: current status and future directions
Okamura, N., Harada, R., Ishiki, A., Kikuchi, A., Nakamura, T., & Kudo, Y. (2018) · Clinical and Translational Imaging · doi:10.1007/s40336-018-0290-y · Cited by 193
Gordon, B. A., Blazey, T. M., Christensen, J., Dincer, A., Flores, S., Keefe, S., Chen, C., Su, Y., McDade, E. M., Wang, G., et al. (2019) · Brain · doi:10.1093/brain/awz019 · Cited by 180
Late-onset vs nonmendelian early-onset Alzheimer disease
Reitz, C., Rogaeva, E. A., & Beecham, G. W. (2020) · Neurology Genetics · doi:10.1212/nxg.0000000000000512 · Cited by 184
Disentangling Heterogeneity in Alzheimer’s Disease and Related Dementias Using Data-Driven Methods
Habes, M., Grothe, M. J., Tunc, B., McMillan, C., Wolk, D. A., & Davatzikos, C. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.01.016 · Cited by 167
A global view of the genetic basis of Alzheimer disease
Reitz, C., Pericak‐Vance, M. A., Foroud, T., & Mayeux, R. P. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00789-z · Cited by 181
Ossenkoppele, R., Lyoo, C. H., Jester-Broms, J., Sudre, C. H., Cho, H., Ryu, Y. H., Choi, J. Y., Smith, R., Strandberg, O., Palmqvist, S., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2019.5154 · Cited by 161
Self-citationVogel, J. W., Corriveau‐Lecavalier, N., Franzmeier, N., Pereira, J. B., Brown, J. A., Maaß, A., Botha, H., Seeley, W. W., Bassett, D. S., Jones, D. T., et al. (2023) · Nature reviews. Neuroscience · doi:10.1038/s41583-023-00731-8 · Cited by 180
Dissecting the clinical heterogeneity of early-onset Alzheimer’s disease
Sirkis, D. W., Bonham, L. W., Johnson, T. P., La Joie, R., & Yokoyama, J. S. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01531-9 · Cited by 151
Rabinovici, G. D., Knopman, D. S., Arbizu, J., Benzinger, T. L. S., Donohoe, K. J., Hansson, O., Herscovitch, P., Kuo, P. H., Lingler, J. H., Minoshima, S., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14338 · Cited by 163
Self-citationThe accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects
Smith, R. A., Strandberg, O. T., Mattsson, N., Leuzy, A., Palmqvist, S., Pontecorvo, M. J., Devous, M. D., Ossenkoppele, R., & Hansson, O. (2020) · Brain · doi:10.1093/brain/awaa327 · Cited by 141
Self-citationDistinct tau PET patterns in atrophy‐defined subtypes of Alzheimer's disease
Ossenkoppele, R., Lyoo, C. H., Sudre, C. H., van Westen, D., Cho, H., Ryu, Y. H., Choi, J. Y., Smith, R. A., Strandberg, O. T., Palmqvist, S., et al. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.08.201 · Cited by 119
Self-citationPredicting future rates of tau accumulation on PET
Jack, C. R., Wiste, H. J., Weigand, S. D., Therneau, T. M., Lowe, V. J., Knopman, D. S., Botha, H., Graff-Radford, J., Jones, D. T., Ferman, T. J., et al. (2020) · Brain · doi:10.1093/brain/awaa248 · Cited by 117
Correlation of In Vivo [18F]Flortaucipir With Postmortem Alzheimer Disease Tau Pathology
Smith, R., Wibom, M., Pawlik, D., Englund, E., & Hansson, O. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2018.3692 · Cited by 111
Self-citationAPOEε4 potentiates the relationship between amyloid-β and tau pathologies
Therriault, J., Benedet, A. L., Pascoal, T. A., Mathotaarachchi, S., Savard, M., Chamoun, M., Thomas, E., Kang, M. S., Lussier, F., Tissot, C., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-0688-6 · Cited by 105
Ossenkoppele, R., Iaccarino, L., Schonhaut, D. R., Brown, J. A., Joie, R. L., O’Neil, J. P., Janabi, M., Baker, S. L., Kramer, J. H., Gorno‐Tempini, M., et al. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101848 · Cited by 109
Self-citationLongitudinal neuroimaging biomarkers differ across Alzheimer’s disease phenotypes
Sintini, I., Graff‐Radford, J., Senjem, M. L., Schwarz, C. G., Machulda, M. M., Martin, P. R., Jones, D. T., Boeve, B. F., Knopman, D. S., Kantarci, K., et al. (2020) · Brain · doi:10.1093/brain/awaa155 · Cited by 99
Harnessing endophenotypes and network medicine for Alzheimer's drug repurposing
Fang, J., Pieper, A. A., Nussinov, R., Lee, G., Bekris, L. M., Leverenz, J. B., Cummings, J. L., & Cheng, F. (2020) · Medicinal Research Reviews · doi:10.1002/med.21709 · Cited by 96
Relationship between amyloid and tau levels and its impact on tau spreading
Doré, V., Krishnadas, N., Bourgeat, P., Huang, K., Li, S., Burnham, S. C., Masters, C. L., Fripp, J., Villemagne, V. L., & Rowe, C. C. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05191-9 · Cited by 93
Pereira, J. B., Ossenkoppele, R., Palmqvist, S., Strandberg, T. O., Smith, R. A., Westman, E., & Hansson, O. (2019) · eLife · doi:10.7554/elife.50830 · Cited by 92
Self-citationFrontzkowski, L. K., Ewers, M., Brendel, M., Biel, D., Ossenkoppele, R., Hager, P., Steward, A., Dewenter, A., Roemer, S. N., Rubinski, A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32592-7 · Cited by 100
Self-citationAmyloid, tau and metabolic PET correlates of cognition in early and late-onset Alzheimer’s disease
Tanner, J. A., Iaccarino, L., Edwards, L., Asken, B. M., Gorno‐Tempini, M. L., Kramer, J. H., Pham, J. Q., Perry, D. C., Possin, K. L., Malpetti, M., et al. (2022) · Brain · doi:10.1093/brain/awac229 · Cited by 91
Molecular imaging in dementia: Past, present, and future
Laforce, R. J., Soucy, J., Sellami, L., Dallaire‐Théroux, C., Brunet, F., Bergeron, D., Miller, B. L., & Ossenkoppele, R. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.06.2855 · Cited by 88
Self-citationTosun, D., Veitch, D. P., Aisen, P. S. S., Jack, C. R., Jagust, W. J., Petersen, R. C., Saykin, A. J., Bollinger, J., Ovod, V., Mawuenyega, K. G., et al. (2021) · Brain Communications · doi:10.1093/braincomms/fcab008 · Cited by 86
Tau Imaging in Neurodegenerative Diseases Using Positron Emission Tomography
Wang, Y. T., & Edison, P. (2019) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-019-0962-7 · Cited by 86
Rabinovici, G. D., Knopman, D. S., Arbizu, J., Benzinger, T. L. S., Donohoe, K. J., Hansson, O., Herscovitch, P., Kuo, P. H., Lingler, J. H., Minoshima, S., et al. (2025) · Journal of Nuclear Medicine · doi:10.2967/jnumed.124.268756 · Cited by 87
Self-citationLongitudinal tau-PET uptake and atrophy in atypical Alzheimer's disease
Sintini, I., Martin, P. R., Graff‐Radford, J., Senjem, M. L., Schwarz, C. G., Machulda, M. M., Spychalla, A. J., Drubach, D. A., Knopman, D. S., Petersen, R. C., et al. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101823 · Cited by 87
Al‐Shaikh, F. S. H., Duara, R., Crook, J. E., Lesser, E. R., Schaeverbeke, J. M., Hinkle, K. M., Ross, O. A., Ertekin‐Taner, N., Pedraza, O., Dickson, D. W., et al. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2019.3606 · Cited by 82
Morris, J. C., Weiner, M., Xiong, C., Beckett, L., Coble, D., Saito, N., Aisen, P. S., Allegri, R., Benzinger, T. L. S., Berman, S. B., et al. (2022) · Brain · doi:10.1093/brain/awac181 · Cited by 68
Malarte, M.-L., Gillberg, P.-G., Kumar, A., Bogdanovic, N., Lemoine, L., & Nordberg, A. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01875-2 · Cited by 67
Tau PET imaging with 18F-PI-2620 in aging and neurodegenerative diseases
Mormino, E. C., Toueg, T. N., Azevedo, E. C., Castillo, J. B., Guo, W., Nadiadwala, A., Corso, N. K., Hall, J. N., Fan, A. P., Trelle, A. N., et al. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-04923-7 · Cited by 67
Alzheimer's disease neuroimaging
Whitwell, J. L. (2018) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000570 · Cited by 67
Longitudinal brain atrophy and CSF biomarkers in early-onset Alzheimer’s disease
Contador, J., Pérez‐Millan, A., Tort‐Merino, A., Balasa, M., Falgàs, N., Olives, J., Castellví, M., Borrego‐Écija, S., Bosch, B., Fernández‐Villullas, G., et al. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102804 · Cited by 64
Topographic staging of tau positron emission tomography images
Schwarz, A. J., Shcherbinin, S., Slieker, L. J., Risacher, S. L., Charil, A., Irizarry, M. C., Fleisher, A., Southekal, S. S., Joshi, A. D., Devous, M. D., et al. (2018) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2018.01.006 · Cited by 63
Determinants of cognitive and brain resilience to tau pathology: a longitudinal analysis
Bocancea, D. I., Svenningsson, A. L., van Loenhoud, A. C., Groot, C., Barkhof, F., Strandberg, O. T., Smith, R. A., Initiative, A. D. N., Weiner, M. W., Aisen, P., et al. (2023) · Brain · doi:10.1093/brain/awad100 · Cited by 59
Self-citationTort‐Merino, A., Falgàs, N., Allen, I. E., Balasa, M., Olives, J., Contador, J., Castellví, M., Juncà‐Parella, J., Guillén, N., Borrego‐Écija, S., et al. (2022) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51689 · Cited by 55
Iaccarino, L., Joie, R. L., Edwards, L., Strom, A., Schonhaut, D. R., Ossenkoppele, R., Pham, J. Q., Mellinger, T. J., Janabi, M., Baker, S. L., et al. (2020) · Cerebral Cortex · doi:10.1093/cercor/bhaa184 · Cited by 56
Self-citationNeuroimaging in aging and neurologic diseases
Risacher, S. L., & Saykin, A. J. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-12-804766-8.00012-1 · Cited by 56
Mundada, N. S., Rojas, J. C., VandeVrede, L. A., Thijssen, E. H., Iaccarino, L., Okoye, O., Shankar, R. P., Soleimani‐Meigooni, D. N., Lago, A. L., Miller, B. L., et al. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01302-w · Cited by 54
The impact of demographic, clinical, genetic, and imaging variables on tau PET status
Ossenkoppele, R., Leuzy, A., Cho, H., Sudre, C. H., Strandberg, O. T., Smith, R. A., Palmqvist, S., Mattsson, N., Olsson, T., Jögi, J., et al. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-05099-w · Cited by 53
Self-citationMolecular Imaging Approaches in Dementia
Villemagne, V. L., Barkhof, F., Garibotto, V., Landau, S. M., Nordberg, A. K., & van Berckel, B. N. M. (2021) · Radiology · doi:10.1148/radiol.2020200028 · Cited by 56
Leuzy, A., Rakêt, L. L., Villemagne, V. L., Klein, G., Tonietto, M., Olafson, E., Baker, S. L., Saad, Z. S., Bullich, S., Lopresti, B. J., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13908 · Cited by 53
Self-citationTimmers, T., Ossenkoppele, R., Wolters, E. E., Verfaillie, S. C. J., Visser, D., Golla, S. S. V., Barkhof, F., Scheltens, P., Boellaard, R., van der Flier, W. M., et al. (2019) · Alzheimer s Research & Therapy · doi:10.1186/s13195-019-0510-3 · Cited by 55
Self-citationThe role of age on tau PET uptake and gray matter atrophy in atypical Alzheimer's disease
Whitwell, J. L., Martin, P. R., Graff‐Radford, J., Machulda, M. M., Senjem, M. L., Schwarz, C. G., Weigand, S. D., Spychalla, A. J., Drubach, D. A., Jack, C. R., et al. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.12.016 · Cited by 48
Breakdown of specific functional brain networks in clinical variants of Alzheimer’s disease
Pini, L., Wennberg, A. M. V., Salvalaggio, A., Vallesi, A., Pievani, M., & Corbetta, M. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101482 · Cited by 48
Wolters, E. E., Dodich, A., Boccardi, M., Corre, J., Drzezga, A. E., Hansson, O., Nordberg, A. K., Frisoni, G. B., Garibotto, V., & Ossenkoppele, R. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-05118-w · Cited by 48
Self-citationSun, N., Mormino, E. C., Chen, J., Sabuncu, M. R., & Yeo, B. T. T. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.116043 · Cited by 47
Young, C. B., Landau, S. M., Harrison, T. M., Poston, K. L., & Mormino, E. C. (2021) · NeuroImage · doi:10.1016/j.neuroimage.2021.118553 · Cited by 46
Interactions between vascular burden and amyloid-β pathology on trajectories of tau accumulation
Coomans, E. M., van Westen, D., Binette, A. P., Strandberg, O. T., Spotorno, N., Serrano, G. E., Beach, T. G., Palmqvist, S., Stomrud, E., Ossenkoppele, R., et al. (2023) · Brain · doi:10.1093/brain/awad317 · Cited by 47
Self-citationWolters, E. E., Ossenkoppele, R., Verfaillie, S. C. J., Coomans, E. M., Timmers, T., Visser, D., Tuncel, H., Golla, S. S. V., Windhorst, A. D., Boellaard, R., et al. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-04758-2 · Cited by 45
Self-citationThe A/T/N model applied through imaging biomarkers in a memory clinic
Dodich, A., Mendes, A., Assal, F., Chicherio, C., Rakotomiaramanana, B., Andryszak, P., Festari, C., Ribaldi, F., Scheffler, M., Schibli, R., et al. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04536-9 · Cited by 43
Imaging of Tau Pathology in Neurodegenerative Diseases: An Update
Beyer, L., & Brendel, M. (2020) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2020.12.004 · Cited by 44
Characterization of MK6240, a tau PET tracer, in autopsy brain tissue from Alzheimer’s disease cases
Malarte, M.-L., Nordberg, A., & Lemoine, L. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-05035-y · Cited by 41
Ni, R., Röjdner, J., Voytenko, L. P., Dyrks, T., Thiele, A., Marutle, A., & Nordberg, A. K. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201344 · Cited by 42
Schwarz, A. J. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01027-4 · Cited by 40
Patterns of tau pathology identified with 18 F‐MK‐6240 PET imaging
Kreisl, W. C., Lao, P. J., Johnson, A. S., Tomljanovic, Z., Klein, J., Polly, K., Maas, B., Laing, K. K., Chesebro, A. G., Igwe, K. C., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12384 · Cited by 42
Thalamic nuclei changes in early and late onset Alzheimer's disease
Forno, G., Saranathan, M., Contador, J., Guillen, N., Falgàs, N., Tort-Merino, A., Balasa, M., Sanchez-Valle, R., Hornberger, M., & Lladó, A. (2023) · Current Research in Neurobiology · doi:10.1016/j.crneur.2023.100084 · Cited by 39
Buciuc, M., Wennberg, A. M. V., Weigand, S. D., Murray, M. E., Senjem, M. L., Spychalla, A. J., Boeve, B. F., Knopman, D. S., Jack, C. R., Kantarci, K., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191040 · Cited by 38
Intermediate flortaucipir uptake is associated with Aβ-PET and CSF tau in asymptomatic adults
McSweeney, M., Binette, A. P., Meyer, P., Gonneaud, J., Bedetti, C., Ozlen, H., Labonté, A., Rosa‐Neto, P., Breitner, J. C. S., Poirier, J., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000008905 · Cited by 41
Comparing cortical signatures of atrophy between late-onset and autosomal dominant Alzheimer disease
Dincer, A., Gordon, B. A., Hari‐Raj, A., Keefe, S., Flores, S. E., McKay, N. S., Paulick, A. M., Shady, K., Feldman, R. L., Hornbeck, R. C., et al. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102491 · Cited by 36
Tau Seeding Mouse Models with Patient Brain-Derived Aggregates
Robert, A., Schöll, M., & Vogels, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116132 · Cited by 37
Self-citation18F-Flortaucipir in TDP-43 associated frontotemporal dementia
Smith, R., Santillo, A. F., Waldö, M. L., Strandberg, O., Berron, D., Vestberg, S., van Westen, D., van Swieten, J., Honer, M., & Hansson, O. (2019) · Scientific Reports · doi:10.1038/s41598-019-42625-9 · Cited by 33
Self-citationQuevenco, F. C., Bergen, J. M. G. V., Treyer, V., Studer, S. T., Kagerer, S. M., Meyer, R., Gietl, A. F., Kaufmann, P. A., Nitsch, R. M., Höck, C., et al. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00046 · Cited by 34
Simrén, J., Brum, W. S., Ashton, N. J., Benedet, A. L., Karikari, T. K., Kvartsberg, H., Sjons, E., Lussier, F. Z., Chamoun, M., Stevenson, J., et al. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01142-0 · Cited by 34
Heterogeneous distribution of tau pathology in the behavioural variant of Alzheimer’s disease
Singleton, E. H., Hansson, O., Pijnenburg, Y. A. L., Joie, R. L., Mantyh, W. G., Tideman, P., Stomrud, E., Leuzy, A., Johansson, M., Strandberg, O. T., et al. (2021) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-325497 · Cited by 32
Self-citationJiang, Z., Wang, J., Qin, Y., Liu, S., Luo, B., Bai, F., Wei, H., Zhang, S., Wei, J., Ding, G., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01392-0 · Cited by 32
Stage, E., Svaldi, D. O., Phillips, M. L., Canela, V. H., Duran, T., Goukasian, N., Risacher, S. L., Saykin, A. J., Apostolova, L. G., & Initiative, A. D. N. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00647-w · Cited by 30
Burnham, S. C., Iaccarino, L., Pontecorvo, M. J., Fleisher, A., Lu, M., Collins, E. C., & Devous, M. D. (2023) · Brain Communications · doi:10.1093/braincomms/fcad305 · Cited by 30
Tau as a biomarker of cognitive impairment and neuropsychiatric symptom in Alzheimer's disease
Dang, M., Chen, Q., Zhao, X. B., Chen, K., Li, X., Zhang, J., Lu, J., Ai, L., Chen, Y., & Zhang, Z. (2022) · Human Brain Mapping · doi:10.1002/hbm.26043 · Cited by 31
Smirnov, D. S., Salmon, D. P., Galasko, D. R., Goodwill, V., Hansen, L. A., Zhao, Y., Edland, S. D., Léger, G. C., Peavy, G. M., Jacobs, D. M., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000013107 · Cited by 31
Mohammadi, Z., Alizadeh, H., Marton, J., & Cumming, P. D. (2023) · Biomolecules · doi:10.3390/biom13020290 · Cited by 28
Age-at-Onset and APOE -Related Heterogeneity in Pathologically Confirmed Sporadic Alzheimer Disease
Smirnov, D. S., Galasko, D., Hiniker, A., Edland, S. D., & Salmon, D. P. (2021) · Neurology · doi:10.1212/wnl.0000000000011772 · Cited by 25
Provost, K., Iaccarino, L., Soleimani‐Meigooni, D. N., Baker, S. L., Edwards, L., Eichenlaub, U., Hansson, O., Jagust, W. J., Janabi, M., Joie, R. L., et al. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-05152-8 · Cited by 27
Self-citationImplication of tau propagation on neurodegeneration in Alzheimer’s disease
Lamontagne-Kam, D., Ulfat, A. K., Hervé, V., Vu, T.-M., & Brouillette, J. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1219299 · Cited by 28
Perani, D., Iaccarino, L., Lammertsma, A. A., Windhorst, A. D., Edison, P., Boellaard, R., Hansson, O., Nordberg, A. K., Jacobs, A. H., & IMBI Project (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.02.004 · Cited by 25
Self-citationDeciphering the clinico-radiological heterogeneity of dysexecutive Alzheimer’s disease
Corriveau‐Lecavalier, N., Barnard, L. R., Lee, J., Dicks, E., Botha, H., Graff‐Radford, J., Machulda, M. M., Boeve, B. F., Knopman, D. S., Lowe, V. J., et al. (2023) · Cerebral Cortex · doi:10.1093/cercor/bhad017 · Cited by 25
[ 18 F]AV‐1451 binding is increased in frontotemporal dementia due to C9orf72 expansion
Bevan-Jones, W. R., Cope, T., Jones, S. P., Passamonti, L., Hong, Y. T., Fryer, T. D., Arnold, R. J., Coles, J., Aigbirhio, F. A., Patterson, K. E., et al. (2018) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.631 · Cited by 26
Imaging of tau deposits in adults with Niemann-Pick type C disease: a case-control study
Villemagne, V. L., Velakoulis, D., Doré, V., Bozinoski, S., Masters, C. L., Rowe, C. C., & Walterfang, M. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-4273-7 · Cited by 23
Mathoux, G., Boccalini, C., Peretti, D. E., Arnone, A., Ribaldi, F., Scheffler, M., Frisoni, G. B., & Garibotto, V. (2024) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-023-06583-9 · Cited by 21
PET Neuroimaging in Dementia Conditions
Perani, D., Caminiti, S. P., Carli, G., & Tondo, G. (2020) · Springer eBooks · doi:10.1007/978-3-030-53168-3_9 · Cited by 20
Lee, W. J., Cho, H., Baek, M. S., Kim, H., Lee, J., Ryu, Y. H., Lyoo, C. H., & Seong, J. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01061-0 · Cited by 20
Llibre‐Guerra, J. J., Iaccarino, L., Coble, D., Edwards, L., Li, Y., McDade, E., Strom, A., Gordon, B. A., Mundada, N. S., Schindler, S. E., et al. (2023) · Brain Communications · doi:10.1093/braincomms/fcad280 · Cited by 21
Lee, E.-C., Kang, J. M., Seo, S., Seo, H., Lee, S., Park, K. H., Na, D. L., Noh, Y., & Seong, J. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.563559 · Cited by 19
Ante‐ and postmortem tau in autosomal dominant and late‐onset Alzheimer’s disease
Chen, C. D., Holden, T. R., Gordon, B. A., Franklin, E. E., Li, Y., Coble, D. W., Luo, H., Bateman, R. J., for the Dominantly Inherited Alzheimer Network (DIAN) and for the Dominantly Inherited Alzheimer Network Trials Unit (DIAN‐TU), Ances, B. M., et al. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51237 · Cited by 19
Visser, D., Verfaillie, S. C. J., Wolters, E. E., Coomans, E. M., Timmers, T., Tuncel, H., Boellaard, R., Golla, S. S. V., Windhorst, A. D., Scheltens, P., et al. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05669-6 · Cited by 19
Self-citationTau: a biomarker of Huntington’s disease
Lepinay, E., & Cicchetti, F. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02230-9 · Cited by 19
Recent Advances in Imaging of Preclinical, Sporadic, and Autosomal Dominant Alzheimer's Disease
Buckley, R. F. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01026-5 · Cited by 18
Metadata
- Authors
- Schöll, M., Ossenkoppele, R., Strandberg, O., Palmqvist, S., study, T. S. B., Jögi, J., Ohlsson, T., Smith, R., & Hansson, O.
- Affiliations
- Lund University (SE)
- Amsterdam Neuroscience (NL)
- Skåne University Hospital (SE)
- Corresponding author
- Schöll, Michael
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-07-16
- Volume
- 140
- Issue
- 9
- Pages
- 2286-2294
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2751819353
- Cited by
- 180
- References
- 28
- Citations by year
- 2026: 8 · 2025: 19 · 2024: 13 · 2023: 24 · 2022: 17 · 2021: 30 · 2020: 29 · 2019: 23 · 2018: 16 · 2017: 1
- FWCI
- 15.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Brain (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, other-oa)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- European Research Council
- Swedish Research Council
- Swedish Brain Foundation
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Keywords
- Alzheimer's disease, early-onset Alzheimer's disease, late-onset Alzheimer's disease, 18F-AV-1451, tau PET, age at symptom onset, prodromal Alzheimer's disease, temporal lobe atrophy, prefrontal cortex, inferior parietal cortex, disease heterogeneity, clinical phenotype
- MeSH terms
- Aged, Aging, Alzheimer Disease, Atrophy, Carbolines, Cerebral Cortex, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Case-Control Studies, tau Proteins, Age of Onset, Tauopathies, Positron-Emission Tomography, Neuroimaging, Prodromal Symptoms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
